跳至主要内容
临床试验/NCT00888849
NCT00888849已完成不适用

An Open-label, Randomized, Prospective Study of the Effectiveness, Safety, and Clinical Outcomes of Stapled Anastomoses Versus Hand-Sutured Anastomoses in Patients Undergoing Gastrointestinal End to End or Side to Side Anastomoses

Ethicon Endo-Surgery6 个研究点 分布在 1 个国家目标入组 280 人开始时间: 2009年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
280
试验地点
6
主要终点
Time of Surgery (Skin Open to Skin Close)

研究概览

简要总结

This study is being conducted to compare surgical and patient outcomes across stapled (Group II) versus hand-sutured (Group I) groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Able to comprehend and sign or, if illiterate, leave their thumb impression on the study informed consent document
  • 18 years to 75 years (inclusive)
  • Admitted on an emergency or elective basis requiring a single gastrointestinal anastomosis
  • Willing to adhere to standard postoperative care, including ventilator support if required
  • Female subject is postmenopausal (for at least 2 years) or surgically incapable of child bearing (at least 3 months post-surgical sterilization, with appropriate documentation)
  • If female subject is capable of child bearing, must use an acceptable method of birth control (hormonal or IUD) for at least 3 months prior to surgery and continue use throughout the study; maintained normal menstrual pattern for the past three months and has a negative urine pregnancy test prior to day of surgical procedure
  • Absence of medical history of psychiatric disorders that could limit the subject's ability to understand the procedure, comply with medical, surgical, and/or behavioral recommendations.

排除标准

  • Women of childbearing potential who are pregnant at the time of screening or at the time of surgery
  • Subject is on treatment with Corticosteroid maintenance therapy (equivalent to > 10mg/day of Prednisone), immunosuppressive or chemotherapeutic agents within 14 days prior to enrollment; or likely to receive one of these drugs during study period
  • Subject has connective tissue disease, renal failure necessitating chronic hemodialysis or chronic ambulatory peritoneal dialysis as evidenced by serum creatinine of > 3mg/dL
  • Subject has liver failure as evidenced by CP category C
  • Immunocompromised subjects (hematological malignancies, history of bone marrow transplantation, splenectomized subjects, genetic disorders such as Lupus, severe combined immunodeficiency, etc.) or a positive HIV test result
  • Subject has extensive disseminated malignancy and unlikely to survive for more than 3 months based on investigator judgment
  • Any subject that the investigator determines is not likely to be compliant during the study period
  • Subjects determined or suspected to engage in substance abuse, or any subject who is currently, or has in the past 6 months, undergone substance abuse therapy
  • The investigator feels that the primary anastomosis is not feasible due to local conditions of the bowel or subject has unstable hemodynamic status requiring stoma
  • Participation in any other investigational device or drug study (non survey based trial) within 30 days of enrollment.

研究组 & 干预措施

Stapling

Experimental

干预措施: Advant 55 Linear Cutter/Stapler (Procedure)

Suturing

Active Comparator

4 layered hand-sutured anastomosis

干预措施: Suturing (Procedure)

结局指标

主要结局

Time of Surgery (Skin Open to Skin Close)

时间窗: Day 1

Time of Anastomosis

时间窗: Total time (minutes) from placement of stay suture to final anastomotic staple (Group II) or final anastomotic suture (Group I)

Return to Bowel Activity

时间窗: Number of days post-surgery to appearance of peristaltic movement

次要结局

未报告次要终点

研究者

发起方
Ethicon Endo-Surgery
申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验